News
All NewsFDA UpdatesPress Releases
Media
All VideosDigital DetailIndependent CornerInsightsInterviewsMEDcastMedical World NewsMicrositesPeer ExchangePerfect ConsultPodcastsPractice PearlsSponsored WebcastStudent VoicesWebinars/Webcasts
Conferences
Conference CoverageConference Listing
Publications
Pharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAll PublicationsAbout the PublicationsAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Pharmacists MonthEducated PatientInformation for the PharmacistInteractive ToolsPartnersPharmacy Times Oncology Pulse Point: Pharmacist InsightsSponsoredWhiteboards

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • ADHD
  • Allergy
  • Alzheimer Disease
  • Anxiety
  • Asthma
  • Atopic Dermatitis
  • Biosimilars
  • Bipolar Disorder
  • Brain Health
  • Breast Cancer
  • C. difficile
  • COPD
  • COVID-19
  • Cardiovascular Health
  • Cervical Cancer
  • Cholangiocarcinoma
  • Cholesterol
  • Chronic Kidney Disease
  • Chronic Lymphocytic Leukemia
  • Classical Hematology
  • Colorectal Cancer
  • Continuous Glucose Monitoring
  • Cough and Cold
  • Depression
  • Dermatology
  • Diabetes
  • Digestive Health
  • Dry Eye Disease
  • Epilepsy
  • Eye Care
  • Flu
  • Future of Pharmacy
  • Gastrointestinal Cancer
  • Gastrointestinal Health
  • Gout
  • HER2 Breast Cancer
  • HIV
  • Heart Failure
  • Hematology
  • Hepatitis/MASH
  • Immunization
  • Immuno-oncology
  • Immunoglobulins
  • Infectious Disease
  • Lung Cancer
  • Lymphoma
  • Macular Degeneration
  • Mental Health
  • Migraine
  • Movement Disorders
  • Multiple Myeloma
  • Multiple Sclerosis
  • Myelofibrosis
  • Neurology
  • Neutropenia
  • Osteoporosis
  • Ovarian Cancer
  • Pain Management
  • Parkinson Disease
  • Pediatrics
  • Pneumococcal
  • PrEP
  • Prostate Cancer
  • Psoriasis
  • Psoriatic Arthritis
  • Psychedelics
  • Reproductive Health
  • Respiratory Syncytial Virus
  • Rheumatoid Arthritis
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep
  • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

a

Advertisement

Articles by a

Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis

ByBrian C. Sauer, PhD,Chia-Chen Teng, MS,Tao He, MS,Jianwei Leng, MS,Chao-Chin Lu, PhD,Jeffrey R. Curtis, MD, MS, MPH,Derek H. Tang, PhD, BSPharm,Neel Shah, PhD, BPharm,David J. Harrison, PhD,a
January 7th 2016

This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.

Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-Release

BySophia Pak, PharmD,Mark Bounthavong, PharmD,Melissa L. Christopher, PharmD,Margaret A. Mendes, PharmD,Emerald B. Foster, PharmD,Daniel T. Boggie, PharmD,Jonathan Lacro, PharmD, BCPS, BCPP,a
February 2nd 2011

Therapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.

Advertisement

Latest Updated Articles

  • Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-Release
    Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-Release

    Published: February 2nd 2011 | Updated:

  • Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis
    Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis

    Published: January 7th 2016 | Updated:



Advertisement
Advertisement

Trending on Pharmacy Times

1

Therapeutic Cancer Vaccines: Are We There Yet?

2

Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education

3

Subcutaneous Amivantamab Shows Promise in EGFR-Mutated Lung Cancer

4

FDA Approves Gazyva for Active Lupus Nephritis

5

Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us